The c-MET-JAK1/2-STAT3 signalling axis is a critical mediator of drug resistance in Kras mutant colorectal cancer

Sandra Van Schaeybroeck, Murugan Kalimutho, Philip Dunne, Robbie Carson, Catherine Fenning, Wendy Moore, Puthen V Jithesh, Heinz-Josef Lenz, Daniel Longley, Patrick Johnston

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Fingerprint

Dive into the research topics of 'The c-MET-JAK1/2-STAT3 signalling axis is a critical mediator of drug resistance in Kras mutant colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences